Back to results
US 2024/0199535 A1Published application
Deuterated dhodh inhibitors
AssigneeImmunic AG
InventorsChristian GEGE, Hella KOHLHOF, Andreas MÜHLER, Daniel VITT
Life of this patent
Estimating the term…
Abstract
The invention relates to novel deuterated compounds of Formula (I) and their use as medicaments.
Claims18
A compound according to Formula (I):
- or an enantiomer, diastereomer, tautomer, prodrug, solvate, or pharmaceutically acceptable salt thereof, wherein
- A is selected from a 5-membered heteroaryl, cyclopentenyl and heterocyclopentenyl, having one or more hydrogen atoms optionally replaced by deuterium,
- said A is unsubstituted or substituted with 1 to 5 substituents independently selected from the group consisting of halogen, CN, NO2, oxo, OH, C1-4-alkyl, O—C1-4-alkyl, fluoro-C1-4-alkyl and O-fluoro-C1-4-alkyl, CO2H and SO3H, having one or more hydrogen atoms in alkyl optionally replaced by deuterium;
- B is selected from the group consisting of 5- to 10-membered cycloalkyl, 4- to 10-membered heterocycloalkyl containing 1 to 4 heteroatoms independently selected from N, O and S, 6- or 10-membered aryl and 5- to 10-membered heteroaryl containing 1 to 6 heteroatoms independently selected from N, O and S,
- wherein cycloalkyl, heterocycloalkyl, aryl and heteroaryl are unsubstituted or substituted with 1 to 4 substituents independently selected from the group consisting of halogen, —CN, —NO2, oxo, C1-4-alkyl, C0-6-alkylene-OR27, C0-6-alkylene-(3- to 6-membered cycloalkyl), C0-6-alkylene-(3- to 6-membered heterocycloalkyl), C0-6-alkylene-S(═O)n(═NR29)mR27, C0-6-alkylene-NR27S(═O)x(═NR29)yR27, C0-6-alkylene-S(═O)x(═NR29)yNR27R28, C0-6-alkylene-NR27 S(═O)x(═NR29)yNR27R28, C0-6-alkylene-CO2R27, C0-6-alkylene-O—COR27, C0-6-alkylene-CONR27R28, C0-6-alkylene-NR27—COR27, C0-6-alkylene-NR27—CONR27R28, C-0-6-alkylene-O—CONR27R28, C0-6-alkylene-NR27—CO2R27, C0-6-alkylene-NR27R28,
- wherein alkyl, alkylene, 3- to 6-membered cycloalkyl and 3- to 6-membered heterocycloalkyl is unsubstituted or substituted with 1 to 6 substituents independently selected from halogen, —CN, oxo, —OH, C1-4-alkyl, halo-C1-4-alkyl, —O—C1-4-alkyl and —O-halo-C1-4-alkyl;
- and wherein optionally two adjacent substituents in the aryl or heteroaryl moiety form a 5- to 8-membered partially unsaturated cycle optionally containing 1 to 3 heteroatoms independently selected from O, S or N, wherein this additional cycle is optionally substituted with 1 to 4 substituents independently selected from halogen, —CN, oxo, —OH, C1-4-alkyl, halo-C1-4-alkyl, —O—C1-4-alkyl and —O-halo-C1-4-alkyl,
- and wherein the residue —NR2 on ring B is in a 1,4-orientation with respect to ring C, ring B or its substituents having one or more hydrogen atoms optionally replaced by deuterium;
- C is selected from the group consisting of 5- to 10-membered cycloalkyl, 4- to 10-membered heterocycloalkyl containing 1 to 4 heteroatoms independently selected from N, O and S, 6- or 10-membered aryl and 5- to 10-membered heteroaryl containing 1 to 6 heteroatoms independently selected from N, O and S,
- wherein cycloalkyl, heterocycloalkyl, aryl and heteroaryl are unsubstituted or substituted with 1 to 4 substituents independently selected from the group consisting of halogen, —CN, —NO2, oxo, C1-4-alkyl, C0-6-alkylene-OR31, C0-6-alkylene-(3- to 6-membered cycloalkyl), C0-6-alkylene-(3- to 6-membered heterocycloalkyl), C0-6-alkylene-S(═O)n(═NR33)mR31, C0-6-alkylene-NR31S(═O)x(═NR33)yR31, C0-6-alkylene-S(═O)x(═NR33)yNR31R32, C0-6-alkylene-NR31 S(═O)x(═NR33)yNR31R32, C0-6-alkylene-CO2R31, C0-6-alkylene-O—COR31, C0-6-alkylene-CONR31R32, C0-6-alkylene-NR31—COR31, C0-6-alkylene-NR31—CONR31R32, C0-6-alkylene-O—CONR31R32, C0-6-alkylene-NR31—CO2R31, C0-6-alkylene-NR31R32,
- wherein alkyl, alkylene, 3- to 6-membered cycloalkyl and 3- to 6-membered heterocycloalkyl is unsubstituted or substituted with 1 to 6 substituents independently selected from halogen, —CN, oxo, —OH, C1-4-alkyl, halo-C1-4-alkyl, —O—C1-4-alkyl and —O-halo-C1-4-alkyl;
- and wherein optionally two adjacent substituents in the aryl or heteroaryl moiety form a 5- to 8-membered partially unsaturated cycle optionally containing 1 to 3 heteroatoms independently selected from O, S or N,
- wherein this additional cycle is optionally substituted with 1 to 4 substituents independently selected from halogen, —CN, oxo, —OH, C1-4-alkyl, halo-C1-4-alkyl, —O—C1-4-alkyl and —O-halo-C1-4-alkyl,
- ring C or its substituents having one or more hydrogen atoms optionally replaced by deuterium;
- X is selected from H, D, halogen, —CN, —NO2, C1-6-alkyl, —O—C1-6-alkyl, O-halo-C1-6-alkyl, C0-6-alkylene-OR41, C0-6-alkylene-(3- to 6-membered cycloalkyl), C0-6-alkylene-(3- to 6-membered heterocycloalkyl), C0-6-alkylene-S(═O)n(═NR43)mR41, C0-6-alkylene-NR41S(═O)x(═NR43)yR41, C0-6-alkylene-S(═O)x(═NR43)yNR41R42, C0-6-alkylene-NR41S(═O)x(═NR43)yNR41R42, C0-6-alkylene-CO2R41, C0-6-alkylene-O—COR41, C0-6-alkylene-CONR41R42, C0-6-alkylene-NR41—COR41, C0-6-alkylene-NR41—CONR41R42, C0-6-alkylene-O—CONR41R42, C0-6-alkylene-NR41—CO2R41, C0-6-alkylene-NR41R42, wherein heterocycloalkyl comprises 1, 2, 3 or 4 heteroatoms independently selected from N, O, or S,
- wherein alkyl, alkylene, cycloalkyl and heterocycloalkyl is unsubstituted or substituted with 1 to 6 substituents independently selected from halogen, —CN, oxo, —OH, C1-4-alkyl, halo-C1-4-alkyl, —O—C1-4-alkyl and —O-halo-C1-4-alkyl,
- X or its substituents having one or more hydrogen atoms optionally replaced by deuterium;
- R1 is selected from H and D;
- R2 is selected from H and C1-6-alkyl,
- wherein alkyl is unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, —CN, C1-4-alkyl, halo-C1-4-alkyl, 3- to 6-membered cycloalkyl, halo-(3- to 6-membered cycloalkyl), 3- to 6-membered heterocycloalkyl, halo-(3- to 6-membered heterocycloalkyl), —OH, oxo, —O—C1-4-alkyl and —O-halo-C1-4-alkyl, wherein heterocycloalkyl comprises 1, 2, 3 or 4 heteroatoms independently selected from N, O, or S,
- R2 or its substituents having one or more hydrogen atoms optionally replaced by deuterium;
- R27, R28, R31, R32, R41, R42 are independently selected from H, C1-6-alkyl, 3- to 6-membered cycloalkyl or 3- to 6-membered heterocycloalkyl,
- wherein alkyl, cycloalkyl or heterocycloalkyl is unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, —CN, C1-4-alkyl, halo-C1-4-alkyl, 3- to 6-membered cycloalkyl, halo-(3- to 6-membered cycloalkyl), 3- to 6-membered heterocycloalkyl, halo-(3- to 6-membered heterocycloalkyl), —OH, oxo, —O—C1-4-alkyl and —O-halo-C1-4-alkyl, wherein heterocycloalkyl comprises 1, 2, 3 or 4 heteroatoms independently selected from N, O, or S,
- R27 and/or R28 and/or R31 and/or R32 and/or R41 and/or R42 or its substituents, respectively, having one or more hydrogen atoms optionally replaced by deuterium;
- or R27 and R28, R31 and R32, R41 and R42, respectively, when taken together with the nitrogen to which they are attached complete a 3- to 6-membered cycle containing carbon atoms and optionally containing 1 or 2 heteroatoms selected from O, S or N;
- and
- wherein this cycle is unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, —CN, C1-4-alkyl, halo-C1-4-alkyl, 3- to 6-membered cycloalkyl, halo-(3- to 6-membered cycloalkyl), 3- to 6-membered heterocycloalkyl, halo-(3- to 6-membered heterocycloalkyl), —OH, oxo, —O—C1-4-alkyl and —O-halo-C1-4-alkyl,
- R27 and/or R28 and/or R31 and/or R32 and/or R41 and/or R42 or its substituents, respectively, having one or more hydrogen atoms optionally replaced by deuterium;
- R29, R33, R43 are independently selected from H, —CN, —NO2, C1-6-alkyl, —CO—O—C1-6-alkyl, 3- to 6-membered cycloalkyl or 3- to 6-membered heterocycloalkyl,
- wherein alkyl, cycloalkyl or heterocycloalkyl is unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, —CN, C1-4-alkyl, halo-C1-4-alkyl, 3- to 6-membered cycloalkyl, halo-(3- to 6-membered cycloalkyl), 3- to 6-membered heterocycloalkyl, halo-(3- to 6-membered heterocycloalkyl), —OH, oxo, —O—C1-4-alkyl and —O-halo-C1-4-alkyl, wherein heterocycloalkyl comprises 1, 2, 3 or 4 heteroatoms independently selected from N, O, or S,
- R29 and/or R33 and/or R43 or its substituents, respectively, having one or more hydrogen atoms optionally replaced by deuterium;
- n, m, x, y are independently selected from 0 to 2;
- with the proviso that the sum of integer m and n for the residue linked to the same sulfur atom is independently selected from 0 to 2;
- with the proviso that the sum of integer x and y for the residue linked to the same sulfur atom is independently selected from 1 or 2;
- provided that at least one hydrogen in A, B, C, R2, R27, R28, R29, R31, R32, R33, R41, R42, R43 and/or X is replaced by deuterium;
- provided, that the level of deuterium incorporation at each substituent designated as deuterium is at least 52.5%.
33 more elements
Dependencies are inferred from the claim text.